-
Prostate cancer clinical trial and targeted treatment preserve quality of life for Northwest Indiana man
20 Dec 2025 01:16 GMT
… enrolling in a clinical trial that offered personalized … .
Reducing prostate cancer side effects
Traditionally, prostate cancer treatment involves … focal therapy treatments for prostate cancer, which use sound … person’s risk of prostate cancer — and biopsy …
-
Can men hold off on treating recurring prostate cancer?
19 Dec 2025 18:47 GMT
… or mortality from their prostate cancer,” Dr. Einstein and … “natural history” of prostate cancers that reappear and are … the process of developing clinical trials for new treatments … other causes before recurring prostate cancer needs treatment. Pre-existing …
-
Prostate Cancer Treatment Market is expected to reach US$ 28.10 billion by 2033 | DataM Intelligence
19 Dec 2025 09:31 GMT
… clinical trials for next-generation prostate cancer therapeutics … prostate cancer treatment. Men with localized prostate tumors … customize/prostate-cancer-treatment-market
… Reports:
Prostate Cancer Biomarker Market
Prostate Cancer Diagnostics …
-
<![CDATA[FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer]]>
18 Dec 2025 02:53 GMT
… metastatic castration-resistant prostate cancer (mCRPC) that … open-label TRITON3 clinical trial which was required … Metastatic Castration-Resistant Prostate Cancer That Expresses … prostate-cancer-expresses-brca-gene-mutation
3. Personalizing Prostate Cancer …
-
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
17 Dec 2025 20:27 GMT
… resistance in advanced prostate cancer,” said Kairos … 2 clinical trial for castrate-resistant prostate cancer and … clinical trials; our success in completing newly initiated clinical trials … : ONCOLOGY HEALTH CLINICAL TRIALS RESEARCH PHARMACEUTICAL SCIENCE …
-
Early PSA Response Predicts Hormone-Sensitive Prostate Cancer
17 Dec 2025 03:14 GMT
… metastatic hormone-sensitive prostate cancer (mHSPC), a … approach could refine clinical trial designs by identifying … in metastatic hormone-sensitive prostate cancer (mHSPC).
Article Title … in metastatic hormone sensitive prostate cancer.
Article References:
…
-
<![CDATA[Clinical strategies for treating metastatic castration-sensitive prostate cancer]]>
17 Dec 2025 01:29 GMT
… management of metastatic castration-sensitive prostate cancer (mCSPC). The conversation centered … , each supported by robust clinical trial data and increasingly used in … long-standing role in metastatic prostate cancer. Panelists emphasized its effectiveness …
-
Monte Rosa Therapeutics Announces Compelling Clinical Activity of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients with Androgen Receptor Mutations
16 Dec 2025 12:00 GMT
… with metastatic castration-resistant prostate cancer (mCRPC). MRT- … treatment landscape of prostate cancer.” “While the … , including castration-resistant prostate cancer (CRPC). In heavily … conduct and complete clinical trials, statements regarding the …
-
Abnormally Activated MNX1 Promotes Tumor Growth and Osimertinib Resistance and Predicts Survival in EGFR-Mutant Lung Adenocarcinoma
20 Dec 2025 08:31 GMT
… in vitro.19 In prostate cancer, MNX1 overexpression upregulates … promoting lipid synthesis in prostate cancer.20 Melo et al … target, further large-scale clinical trials are needed to validate … upregulated in african-american prostate cancer. Cancer Res. 2016; …
-
<![CDATA[China’s NMPA Accepts New Drug Application for Tinengotinib Tablets for Advanced Cholangiocarcinoma]]>
19 Dec 2025 22:12 GMT
… cholangiocarcinoma, breast cancer, prostate cancer, and liver cancer.
… data from 4 clinical trials investigating tinengotinib tablets … global phase 3 clinical trial for cholangiocarcinoma authorized … global-phase-3-clinical-trial-for-cholangiocarcinoma- …
About
© 1995-2025